- Home
- DVA vs NICE Comparison
DVA vs NICE Comparison
Compare DVA & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- NICE
- Stock Information
- Founded
- DVA 1994
- NICE 1986
- Country
- DVA United States
- NICE Israel
- Employees
- DVA N/A
- NICE N/A
- Industry
- DVA Misc Health and Biotechnology Services
- NICE Computer Software: Prepackaged Software
- Sector
- DVA Health Care
- NICE Technology
- Exchange
- DVA Nasdaq
- NICE Nasdaq
- Market Cap
- DVA 10.9B
- NICE 10.3B
- IPO Year
- DVA 1995
- NICE 1996
- Fundamental
- Price
- DVA $142.56
- NICE $170.19
- Analyst Decision
- DVA Hold
- NICE Buy
- Analyst Count
- DVA 4
- NICE 12
- Target Price
- DVA $157.00
- NICE $209.75
- AVG Volume (30 Days)
- DVA 857.4K
- NICE 413.2K
- Earning Date
- DVA 08-05-2025
- NICE 08-14-2025
- Dividend Yield
- DVA N/A
- NICE N/A
- EPS Growth
- DVA 14.90
- NICE 28.89
- EPS
- DVA 10.11
- NICE 7.17
- Revenue
- DVA $12,968,524,000.00
- NICE $2,776,155,000.00
- Revenue This Year
- DVA $6.46
- NICE $8.98
- Revenue Next Year
- DVA $3.24
- NICE $6.91
- P/E Ratio
- DVA $14.10
- NICE $23.18
- Revenue Growth
- DVA 5.11
- NICE 12.63
- 52 Week Low
- DVA $131.76
- NICE $137.19
- 52 Week High
- DVA $179.60
- NICE $200.65
- Technical
- Relative Strength Index (RSI)
- DVA 55.72
- NICE 56.27
- Support Level
- DVA $135.07
- NICE $166.06
- Resistance Level
- DVA $147.45
- NICE $169.74
- Average True Range (ATR)
- DVA 3.05
- NICE 3.85
- MACD
- DVA 0.82
- NICE -0.08
- Stochastic Oscillator
- DVA 61.83
- NICE 87.86
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About NICE NICE Ltd
NICE Ltd is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.